132
Views
12
CrossRef citations to date
0
Altmetric
Review

Impact of HIV on standard case management for severe pneumonia in children

, , , &
Pages 211-220 | Published online: 09 Jan 2014

References

  • United Nations. Progress since the world summit for children: a statistical review. UNICEF, NY, USA (2001).
  • Rudan I, Boschi-Pinto C, Biloglav Z, Mulhollandd K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull. World Health Organ.86, 408–416 (2008).
  • Prendergast A, Tudor-William GP, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet370(9581), 68–80 (2007).
  • Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the global HIV/AIDS epidemic 2008: executive summary. UNAIDS/08.27E/JC1511E. UNAIDS, Geneva, Switzerland (2008).
  • United Nations Programme on HIV/AIDS.UNAIDS epidemic update: December 2005. UNAIDS/WHO, Geneva, Switzerland (2005).
  • Graham SM, Coulter JB, Gilks CF. Pulmonary disease in HIV-infected African children. Int. J. Tuberc. Lung Dis.5(1), 12–23 (2001).
  • Graham SM. HIV-related pulmonary disorders: practice issues. Ann. Trop. Paediatr.27, 243–252 (2007).
  • Gray D, Zar HJ. Management of community acquired pneumonia in HIV infected children. Expert Rev. Anti Infect. Ther.7(4), 437–451 (2009).
  • Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin. Infect. Dis.31, 170–176 (2000).
  • Graham SM, Mtitimila EI, Kamanga HS, Walsh AL, Hart CA, Molyneux ME. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet355, 369–373 (2000).
  • Ansari NA, Kombe AH, Kenyon TA et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997–1998. Pediatr. Infect. Dis. J.22(1), 43–47 (2003).
  • Perez Mato S, van Dyke RB. Pulmonary infections in children with HIV infection. Semin. Respir. Infect.17, 33–46 (2002).
  • Chintu C, Mudenda V, Lucas S et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet360(9338), 985–990 (2002).
  • Zar HJ, Hanslo D, Tannenbaum E et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr.90, 119–125 (2001).
  • Bakeera-Kitaka S, Musoke P, Downing R, Tumwine JK. Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda. Ann. Trop. Paediatr.24, 227–235 (2004).
  • McNally LM, Jeena PM, Gajee K et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet369, 1440–1451 (2007).
  • Madhi SA, Schoub B, Simmank K et al. Increased burden of respiratory viral associated severe lower respiratory tract infections in children with human immunodeficiency virus type-1. J. Pediatr.137(1), 78–84 (2000).
  • Hesseling AC, Cotton MF, Jennings T et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin. Infect. Dis.48(1), 108–114 (2009).
  • Madhi SA, Ramasamy N, Bessellar TG, Saloojee H, Klugman KP. Lower respiratory tract infections associated with influenza A and B viruses in an area with a high prevalence of pediatric human immunodeficiency type 1 infection. Pediatr. Infect. Dis. J.21, 291–297 (2002).
  • Mulholland K. Magnitude of the problem of childhood pneumonia. Lancet354, 590–592 (1999).
  • Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect. Dis.2, 25–32 (2002).
  • United Nations. State of the world’s children 2004. Girls, education and development. United Nations Children’s Fund (UNICEF). NY, USA (2004).
  • Wardlaw T, Johansson EW, Hodge M. Pneumonia: the forgotten killer of children. United Nations Children’s Fund (UNICEF)/World Health Organization (WHO) (2006).
  • Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull. World Health Organ.82, 895–903 (2004).
  • Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat. Q.45(2–3), 180–191 (1992).
  • Shann F, Hart K, Thomas D. Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull. World Health Organ.81, 301–305 (1984).
  • World Health Organization. Acute respiratory infection; case management in small hospitals in developing countries. WHO/ARI/90.5. WHO, Geneva, Switzerland (1990).
  • Pio A. Standard case management of pneumonia in children in developing countries: the cornerstone of the acute respiratory infection programme. Bull. World Health Organ.81, 298–300 (2003).
  • Shann F. The management of pneumonia in children in developing countries. Clin. Infect. Dis.21(Suppl. 3), S218–S225 (1995).
  • Cherian T, Steinhoff MC, Simoes E, John J. Clinical signs of acute lower respiratory tract infections in malnourished infants and children. Pediatr. Infect. Dis. J.5, 247–252 (1986).
  • Riley ID. Technical bases for the standardization of clinical management of ARI in Papua New Guinea. WHO/RSD/81.7. WHO, Geneva, Switzerland (1981).
  • Cherian T, John TJ, Simoes E et al. Evaluation of simple clinical signs for the diagnosis of acute lower respiratory tract infection. Lancet16, 125–128 (1988).
  • Harari M, Shann F, Spooner V, Meisner S, Carney M, de Campo J. Clinical signs of pneumonia in children. Lancet338(8772), 928–930 (1991).
  • Mulholland EK, Simoes EAF, Costales MOD et al. Standardized diagnosis of pneumonia in developing countries. Pediatr. Infect. Dis. J.11, 77–81 (1992).
  • Gove S, Pio A, Campbell H, Cattaneo A. WHO guidelines on detecting pneumonia in children. Lancet338, 1453 (1991).
  • Falade AG, Tschappeler H, Greenwood BM, Mulholland EK. Use of simple clinical signs to predict pneumonia in young Gambian children: the influence of malnutrition. Bull. World Health Organ.73, 299–304 (1995).
  • Reuland DS, Steinhoff MC, Gilman RH et al. Prevalence and prediction of hypoxemia in children with respiratory infections in the Peruvian Andes. J. Pediatr.119(6), 900–906 (1991).
  • Campbell H, Byass P, Lamont AC et al. Assessment of clinical criteria for identification of severe acute lower respiratory tract infection in children. Lancet1(8633), 297–299 (1989).
  • Lozano JM, Steinhoff M, Ruiz JG, Mesa ML, Martinez N, Dussan B. Clinical predictors of acute radiological pneumonia and hypoxaemia at high altitude. Arch. Dis. Child.71(4), 323–327 (1994).
  • Shann F. The use of antibiotics in children in Papua New Guinea. WHO Report No. WHO/RSD/81.4. WHO, Geneva, Switzerland (1981).
  • Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr. Infect. Dis.5(2), 247–252 (1986).
  • Ghafoor A, Nomani NK, Ishaq Z et al. Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan. Rev. Infect. Dis.12(Suppl. 8), S907–S914 (1990).
  • Barker J, Gratten M, Riley I et al. Pneumonia in children in the eastern highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. J. Infect. Dis.159(2), 348–352 (1989).
  • Tupasi TE, Lucero MG, Magdangal DM et al. Etiology of acute lower respiratory tract infection in children from Alabang, Metro Manila. Rev. Infect. Dis.12(Suppl. 8), S929–S939 (1990).
  • Banya WA, O’Dempsey TJ, Mcardle T, Lloyd-Evans N, Greenwood BM. Predictors for a positive blood culture in African children with pneumonia. Pediatr. Infect. Dis. J.15(4), 292–297 (1996).
  • World Health Organization. Antibiotics in the treatment of acute respiratory infections in young children. WHO/ARI/90.10. WHO, Geneva, Switzerland (1990).
  • Berman S, Duenas A, Bedoya A et al. Acute lower respiratory tract illnesses in Cali, Columbia: a two year ambulator study. Pediatrics71(2), 210–218 (1983).
  • Reed SE. The etiology and epidemiology of common colds and possibilities of prevention. Clin. Otolaryngol.6(6) 379–387 (1981).
  • Murphy TF, Henderson FW, Clyde WA Jr, Collier AM, Denny FW. Pneumonia: an eleven year study in pediatric practice. Am. J. Epidemiol.113(1), 12–21 (1981).
  • Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect. Dis.3(9), 547–556 (2003).
  • World Health Organization. Technical updates of the guidelines on the Integrated Management of Childhood Illness (IMCI): evidence and recommendations for further adaptations. WHO, Geneva, Switzerland (2005).
  • World Health Organization. Pocket book of hospital care for children: guidelines for the management of common illnesses with limited resources. WHO, Geneva, Switzerland (2005).
  • Grant GB, Campbell H, Dowell SF et al.; World Health Organization Department of Child and Adolescent Health and Development. Recommendations for treatment of childhood non-severe pneumonia. Lancet Infect. Dis.9, 185–196 (2009).
  • Addo-Yobo E, Chisaka N, Hassan M et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet364, 1141–1148 (2004).
  • Duke T, Poka H, Dale F, Michael A, Mgone J, Wal T. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet359, 474–480 (2002).
  • Asghar R, Banajeh S, Egas J et al.; Severe Pneumonia Evaluation Antimicrobial Research Study Group. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2–59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ336, 80–84 (2008).
  • Smyth A, Tong CY, Carty H, Hart CA. Impact of HIV on mortality from acute lower respiratory tract infection in rural Zambia. Arch. Dis. Child.77(3), 227–230 (1997).
  • Jeena PM, Minkara AK, Corr P et al. Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community acquired severe pneumonia. Arch. Dis. Child.92(11), 976–979 (2007).
  • Sigaúque B, Roca A, Bassat Q et al. Severe pneumonia in Mozambican young children: clinical and radiological characteristics and risk factors. J. Trop. Pediatr.55(6), 379–387 (2009).
  • World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV infections among children, adolescents and adults in resource-limited settings: recommendations for a public health approach. WHO, Geneva, Switzerland (2006).
  • Graham SM, English M, Hazir T, Enarson P, Duke T. Challenges to improving case management of childhood pneumonia at health facilities in resource-limited settings. Bull. World Health Organ.86(5), 349–355 (2008).
  • Chokephaibulkit K, Wanachiwanawin D, Chearskul S et al. Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy. Pediatr. Infect. Dis. J.18, 147–152 (1999).
  • Fassinou P, Elenga N, Rouet F et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d’Ivoire. AIDS18, 1905–1913 (2004).
  • Jeena P, Thea DM, MacLeod WB et al.; Amoxicillin Penicillin Pneumonia International Study (APPIS Group). Failure of standard antimicrobial therapy in children aged 3–59 months with mild or asymptomatic HIV infection and severe pneumonia. Bull. World Health Organ.84, 269–275 (2006).
  • Zar HJ, Dechaboon A, Hanslo D, Apolles P, Magnus KG, Hussey G. Pneumocystis cariniipneumonia in South African children infected with human immunodeficiency virus. Pediatr. Infect. Dis. J.19, 603–607 (2000).
  • Nathoo KJ, Gondo M, Gwanzura L, Mhlanga BR, Mavetera T, Mason PR. Fatal Pneumocystis carinii pneumonia in HIV-seropositive infants in Harare, Zimbabwe. Trans. R. Soc. Trop. Med. Hyg.95(1), 37–39 (2001).
  • Ikeogu MO, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch. Dis. Child.76(2), 124–128 (1997).
  • Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann. Trop. Paediatr.16(4), 361–368 (1996).
  • Madhi SA, Petersen K, Khoosal M et al. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. Pediatr. Infect. Dis. J.21, 315–321 (2002).
  • Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med.349(14), 1341–1348 (2003).
  • Graham SM, English M. Nontyphoidal salmonellae: a management challenge for children with community acquired invasive disease in tropical African countries. Lancet372, 267–269 (2009).
  • Graham SM. Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children. Int. J. Tuberc. Lung Dis.9(6), 592–602 (2005).
  • Zar HJ, Jeena P, Argent A, Gie R, Madhi SA; Working Groups of the Paediatric Assembly of the South African Thoracic Society. Diagnosis and management of community-acquired pneumonia in childhood – South African Thoracic Society Guidelines. S. Afr. Med. J.95(12 Pt 2), 977–981, 984–990 (2005).
  • World Health Organization. Management of children with pneumonia and HIV in low-resource settings. Report of a consultative meeting. Harare, Zimbabwe, Jan 30–31, 2003. WHO, Geneva, Switzerland (2004).
  • Moodley D, Moodley J, Coovadia H et al.; South African Intrapartum Nevirapine Trial (SAINT) Investigators. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis.187(5), 725–735 (2003).
  • Chintu C, Bhat GJ, Walker AS et al.; CHAP trial team. Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo controlled trial. Lancet364(9448), 1865–1871 (2004).
  • Violari A, Cotton MF, Gibb DM et al.; CHER Study Team. Early anti-retroviral therapy and mortality among HIV-infected infants. N. Engl. J. Med.359(21), 2233–2244 (2008).
  • World Health Organization. Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. WHO, Geneva, Switzerland (2009).
  • World Health Organization. Guidelines on cotrimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: recommendations for a public health approach. WHO, Geneva, Switzerland (2006).
  • World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings, towards universal access: recommendations for a public health approach. WHO, Geneva, Switzerland (2006).
  • Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges of childhood TB in the era of HIV. J. Infect. Dis.196(Suppl. 1), S76–S85 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.